Navamedic ASA Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Navamedic ASA stock have an average target of kr 21.00, which predicts a 40.47% increase from the current stock price of 14.95.

Price Target: kr 21.00 (+40.47%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	kr 21.00	kr 21.00	kr 21.00	kr 21.00
Change	+40.47%	+40.47%	+40.47%	+40.47%

Analyst Ratings

The average analyst rating for Navamedic ASA stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Dec '25	Jan '26	Feb '26	Apr '26	Jul '26	Aug '26
Strong Buy	0	0	0	0	1	1
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	2	2

Financial Forecast

Revenue This Year

574.33M

from 565.36M

1.59%

from 565.36M

Revenue Next Year

609.95M

from 574.33M

6.20%

from 574.33M

EPS This Year

-0.19

from -1.03

EPS Next Year

0.31

from -0.19

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	278.44M	382.14M	512.00M	531.44M	565.36M	574.33M
Revenue Growth	32.67%	37.24%	33.98%	3.80%	6.38%	1.59%
Gross Profit	111.74M	163.52M	198.37M	205.52M	217.57M	231.46M
Gross Margin	40.13%	42.79%	38.74%	38.67%	38.48%	40.30%
Operating Income	11.46M	44.45M	39.64M	31.80M	16.25M	11.95M
Net Income	618.00K	29.43M	-13.69M	-5.49M	-23.54M	-7.50M
EPS	-	-	-	-	-1.03	-0.19
Free Cash Flow	-40.58M	-15.57M	77.88M	2.99M	39.87M	38.90M
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is NOK.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	580.7M
Avg	574.3M
Low	568.0M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	2.7%
Avg	1.6%
Low	0.5%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-0.17
Avg	-0.19
Low	-0.21

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-